Summary:
Ulcerative Proctitis / Proctosigmoiditis Clinical Trial
New Investigational Therapeutic Option
Wake Research Associates is conducting a clinical research trial for patients suffering from active UP/UPS with mild to moderate symptoms.
The trial is a randomized, multicenter study providing an investigational new treatment option for active UP/UPS with mild to moderate symptoms: budesonide foam.
Primary Objective
To determine the safety and effectiveness of budesonide foam as compared to placebo through six weeks of study treatment.
Qualified Participants Must:
• Be 18-75 years of age
•
Have active ulcerative proctitis or proctosigmoiditis
•
Have no use of corticosteroids within 30 days of study entry
•
Have no other active gastrointestinal disease
Qualified Participants May Receive:
Study-related medical examinations and study medication at no cost. Compensation may be provided for time and travel.